Neuraxis, Inc.
Biotechnology
Healthcare
NRXS
7.46 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
2.73
52 week high
3.99
high
2.75
52 week low
0.00
previous Close
2.69
P/E ratio
market cap
23.44 M
div yield
0
net profit margin
0.00 %
254.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top